Modular imaging device scores well

Article

The recently launched EyeScan modular ocular imaging device provides high-quality images and has the potential to save practices time and money, according to one proponent.

Dallas-The recently launched EyeScan modular ocular imaging device (Ophthalmic Imaging Systems [OIS]) provides high-quality images and has the potential to save practices time and money, said Todd Agnew, OD, a private practitioner in Dallas who was involved in beta-testing the unit.

The portable device captures both anterior and posterior segment views through six interchangeable imaging modules and can transition from capturing one type of image to another without moving the patient or the device. The device received 510(k) market clearance from the Food and Drug Administration in December.

Selling points

"What I found is that relative to the other cameras that require a decent skill set in order to capture a clear image, [the device] is much easier to go ahead and use, and even people who aren't really experienced taking pictures of the back or front surface of the eye have gotten clear pictures for me," he said. "Without a doubt, the majority of the images have been clear and easy to take."

"It's a valuable time-saver if you don't have to spend lots of time training somebody to help take those images," he said.

He also noted that the device can obtain 5.3-megapixel images, which provide better detail than images produced by some other imaging equipment, as well as capture live video segments. The maximum image capture rate is three images per second.

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.